Spinal muscular atrophy  community-oneSMAvoice

If you are a doctor or other qualified health care professional, you should not offer any medical advice or treatment on our Sites, nor should you allow the content of our Sites to substitute for your own medical judgment. Please thoroughly review the information provided on our Sites before deciding whether any of the products, services, or treatments therein are right for you or others.

oneSMAvoice
  • Social Wall
  • Trusted Resources
    • EducationScientific literature & patient education texts
    • People & PlacesHealthcare providers, researchers, & advocates
    • Community CenterOnline groups, photo galleries, & blogs
    • News & MeetingsLatest announcements & gatherings
    • Videos & VisualsChannels, infographics, & slides
  • Clinical Trial Education
Global Search
Global Search
  • Social Wall Social Wall
  • Trusted Resources Trusted Resources
    • Trusted Resources Home

    • Education

      Scientific literature & patient education texts
    • People & Places

      Healthcare providers, researchers, & advocates
    • Community Center

      Online groups, photo galleries, & blogs
    • News & Meetings

      Latest announcements & gatherings
    • Videos & Visuals

      Channels, infographics, & slides
  • rareClinical Clinical Trial Education
  • my Account
Global Search
Log in
Register
en English
en Englishes Spanish
  • Register
  • Log in
en English
en Englishes Spanish

    contact us
    have a question, issue or just some feedback for us? we're here for you.



    DISCLAIMER

    The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.
    compose your message

      *

      *


      message

      *

      message sent

      email sent successfully

      suggest a poll

      you must have an account to suggest polls.

      join now

      rareLife solutions 606 Post Road East #397
      Westport, CT 06880
      You are receiving this because you have an account on www.oneSMAvoice.com
      If you'd like to unsubscribe and stop receiving these emails click here

      Trusted Resources: News & Meetings

      Latest announcements and gatherings

      • Clinical Trial and Research
      • Business
      • People
      • Spotlight
      • Happenings
      Back to News & Meetings / Clinical Trial And Research

      Biogen Announces New Updates Across Its SMA Research Program at 2022 MDA Conference


      Biogen Inc. announced new data and updates from its SPINRAZA® (nusinersen) and spinal muscular atrophy (SMA) research program aimed at improving clinical outcomes for people impacted by the disease, including the ASCEND, RESPOND and NURTURE studies. These updates were presented at the 2022 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference (March 13-16, 2022).

      First Patient Treated in Phase 3b ASCEND Study

      The ASCEND study is currently enrolling with the first patient treated in Q1 2022. At the conference, Biogen presented the design of the open-label, global Phase 3b study to evaluate the potential benefit of investigational higher dose nusinersen in later-onset, non-ambulatory SMA patients previously treated with Evrysdi® (risdiplam).

      “As the SMA community gains more experience with available therapies, we are gleaning new insights about how these treatments can enhance the lives of individuals impacted by SMA. However, unmet needs still remain for the community,” said Basil Darras, M.D., Professor of Neurology at Harvard Medical School and Director of the Neuromuscular Center and Spinal Muscular Atrophy Program at Boston Children’s Hospital. “The ASCEND study seeks to generate data that have the potential to inform decisions regarding treatment for our patients with later-onset SMA.”

       

      Biogen Announces New Updates Across Its SMA Research Program At 2022 MDA Conference
      Source: https://www.globenewswire.com/news-release/2022/03/14/2402455/0/en/Biogen-Announces-New-Updates-Across-its-SMA-Research-Program-at-2022-MDA-Conference.html
      Share
      Discuss in Social Wall
      Share to rareTeam
      Bookmark

      Related Content

      • News & Meetings
        Will Parental Vaccine Hesitancy Retard the Embrace of Life-Saving Newborn Genetic Screening and Emerging Gene Therap...
        In these days of the never-ending pandem...
      • Education
        Assessment of Cerebral Spinal Fluid Biomarkers and microRNA-Mediated Disease Mechanisms in Spinal Muscular Atrophy P...
        Cerebral spinal fluid (CSF) is a promisi...
      • Education
        Nusinersen for Spinal Muscular Atrophy in the United States: Findings From a Retrospective Claims Database Analysis
        Spinal muscular atrophy (SMA) is a rare,...
      • Education
        Safety and Efficacy of Once-Daily Risdiplam in Type 2 and Non-Ambulant Type 3 Spinal Muscular Atrophy (SUNFISH Part ...
        Background: Risdiplam is an oral small m...
      • Education
        Pharmacological and Clinical Profile of Onasemnogene Aveparvovec, the First Gene Therapy for Spinal Muscular Atrophy...
        Onasemnogene abeparvovec (Zolgensma; for...
      • People & Places
        John Hopkins – Spinal Muscular Atrophy (SMA) Center
        The Spinal Muscular Atrophy (SMA) Center...
      • Videos & Visuals
        SMA Gene Replacement Therapy
        https://www.youtube.com/watch?v=vHbJs8bm...

      send a message

      send to:
      subject:
      message:
      Back to Top
      edit tags:

      Reset password

      Enter Phone Number

      Enter the code

      Almost done!
      We just send a four digit code to your mobile number. Enter it here to login!
      Didn't receive the code?Re-send
      Or login in with your password instead

      password changed successfully!

      oneSMAvoice

      please log in with your email address and new password.

      your activation key expired

      oneSMAvoice

      this confirmation key has expired. please try to log in again or resend confirmation email.

      confirmation email sent

      oneSMAvoice

      a confirmation email has been sent to your inbox. click the link in the email to activate your account.
      can't find the email? be sure to check your spam folder.

      password reset email sent

      oneSMAvoice

      an email has been sent to you with a link to reset your password.
      can't find the email? be sure to check your spam folder.

      oneSMAvoice

      If you are a doctor or other qualified health care professional, you should not offer any medical advice or treatment on our Sites, nor should you allow the content of our Sites to substitute for your own medical judgment. Please thoroughly review the information provided on our Sites before deciding whether any of the products, services, or treatments therein are right for you or others.

      your account is now activated!

      oneSMAvoice
      • register
      • log in

      Join the community

      You need an account to use this feature.

      Already have an account? Log in.

      I have read and understand the oneSMAvoice privacy policy and terms of use.

      Almost done!
      We just sent a four digit code to your mobile number. Enter it here to log in!
      Please Wait!!!
      Didn't receive the code? Re-send
      Or log in in with your password instead

      Log in

      You need to log in to use this feature.

      Don't have an account? Click here to register.

      you haven't confirmed your email address yet. resend confirmation email

      Forget your password? Reset here.
      Or log in with a one-time code
      or register with

      login with:


      Need to get in touch?

      Powered by

      In partnership with

      • About Us
      • FAQs
      • Legal & Privacy
      • Contact Us
      © 2023 rareLife solutions Inc.